Supplementary material 1 to:
Fluvoxamine for the treatment of COVID-19

Nyirenda JLZ, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-taha A, Maun A, Stegemann M, Schmucker C
https://doi.org/10.1002/14651858.CD015391

Cochrane disclaims all liability and responsibility arising from any reliance placed on this supplementary material which has been supplied by the author(s). The above associated publication’s Author Licence will apply in respect of any supplemental materials published. How to cite the supplementary material is defined in the Cochrane policy.

Back to top

Search strategies

Search strategies

Cochrane COVID‐19 Study Register

fluvoxamin* or luvox* or floxyfral* or fevarin* or faverin* or fluvoxadura* or dumirox* or desiflu*

Web of Science (Core Collection) – Science Citation Index and Emerging Sources Citation Index

#1 TI=((COVID OR COVID19 OR "SARS-CoV-2" OR "SARS-CoV2" OR SARSCoV2 OR "SARSCoV-2" OR "SARS coronavirus 2" OR "2019 nCoV" OR "2019nCoV" OR "2019-novel CoV" OR "nCov 2019" OR "nCov 19" OR "severe acute respiratory syndrome coronavirus 2" OR "novel coronavirus disease" OR "novel corona virus disease" OR "corona virus disease 2019" OR "coronavirus disease 2019" OR "novel coronavirus pneumonia" OR "novel corona virus pneumonia" OR "severe acute respiratory syndrome coronavirus 2"))) OR AB=((COVID OR COVID19 OR "SARS-CoV-2" OR "SARS-CoV2" OR SARSCoV2 OR "SARSCoV-2" OR "SARS coronavirus 2" OR "2019 nCoV" OR "2019nCoV" OR "2019-novel CoV" OR "nCov 2019" OR "nCov 19" OR "severe acute respiratory syndrome coronavirus 2" OR "novel coronavirus disease" OR "novel corona virus disease" OR "corona virus disease 2019" OR "coronavirus disease 2019" OR "novel coronavirus pneumonia" OR "novel corona virus pneumonia" OR "severe acute respiratory syndrome coronavirus 2")

#2 (TI=((fluvoxamin* or luvox* or floxyfral* or fevarin* or faverin* or fluvoxadura* or dumirox* or desiflu*))) OR AB=((fluvoxamin* or luvox* or floxyfral* or fevarin* or faverin* or fluvoxadura* or dumirox* or desiflu*))

#3 #1 AND #2

WHO COVID‐19 Global literature on coronavirus disease

(fluvoxamin* or luvox* or floxyfral* or fevarin* or faverin* or fluvoxadura or dumirox* or desiflu*)